Lenalidomide + Rituximab

From OncoWiki
Jump to: navigation, search

Chronic Lymphocytic Leukemia

  • Lenalidomide (Revlimid) 25 mg po qd d1-21
  • Rituximab (Rituxan) 375 mg/m2 iv d1, 8 and 15 of cycle 1, then d1 and 15 of cycles 2-6

Q4w

References

  • Chanan-Khan A et al. Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: Results of a phase II study. J Clin Oncol 2006; 24:5343
Retrieved from "http://oncowiki.info/index.php?title=Lenalidomide_%2B_Rituximab&oldid=463"